Assessment of gender differences in some inflammatory cytokines of tuberculosis patients before and during treatment.

Tuberculosis anti-tuberculosis drugs cytokines inflammation

Journal

African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 15 2 2024
pubmed: 15 2 2024
entrez: 15 2 2024
Statut: ppublish

Résumé

Gender variation is a feature of many physiological parameters including inflammatory cytokines. Inflammation is an obvious feature of Tuberculosis (TB) infection with changes in pro and anti-inflammatory cytokines. To compare the levels of inflammatory cytokines between male and female TB patients before treatment, after 2-months and after 6-months anti-tuberculosis treatment. A total of 35 males and 25 females TB subjects were enlisted before initiation of therapy and followed up after 2-months and 6 months treatment and samples collected and analysed. Tumour necrosis factor-alpha (TNF-α), Interleukin 10 (IL-10, Interleukin -6 (IL-6), Interleukin-2 (IL-2), transforming growth factor-beta (TGF-β) were assayed by ELISA method. Before treatment, the median level of IL-6 (pg/ml) was significantly higher in males compared to female TB patients (P=0.046). While after 2-months treatment, TNF-α (pg/ml) and IL-10 (pg/ml) was significantly higher in males compared with females (P=0.008 and 0.045 respectively). Conversely, the median IL-6 (pg/ml) was significantly higher in female TB patients compared to the males (P=0.042). No significant differences were observed after 6-months treatment. Gender differences exist in IL-6 before treatment and in IL-6, TNF-α and IL-10 at two months treatment. Thus, TB treatment contributes differentially to levels of inflammatory cytokines in male and female TB patients.

Sections du résumé

Background UNASSIGNED
Gender variation is a feature of many physiological parameters including inflammatory cytokines. Inflammation is an obvious feature of Tuberculosis (TB) infection with changes in pro and anti-inflammatory cytokines.
Objective UNASSIGNED
To compare the levels of inflammatory cytokines between male and female TB patients before treatment, after 2-months and after 6-months anti-tuberculosis treatment.
Materials and methods UNASSIGNED
A total of 35 males and 25 females TB subjects were enlisted before initiation of therapy and followed up after 2-months and 6 months treatment and samples collected and analysed. Tumour necrosis factor-alpha (TNF-α), Interleukin 10 (IL-10, Interleukin -6 (IL-6), Interleukin-2 (IL-2), transforming growth factor-beta (TGF-β) were assayed by ELISA method.
Results UNASSIGNED
Before treatment, the median level of IL-6 (pg/ml) was significantly higher in males compared to female TB patients (P=0.046). While after 2-months treatment, TNF-α (pg/ml) and IL-10 (pg/ml) was significantly higher in males compared with females (P=0.008 and 0.045 respectively). Conversely, the median IL-6 (pg/ml) was significantly higher in female TB patients compared to the males (P=0.042). No significant differences were observed after 6-months treatment.
Conclusion UNASSIGNED
Gender differences exist in IL-6 before treatment and in IL-6, TNF-α and IL-10 at two months treatment. Thus, TB treatment contributes differentially to levels of inflammatory cytokines in male and female TB patients.

Identifiants

pubmed: 38357187
doi: 10.4314/ahs.v23i3.40
pii: jAFHS.v23.i3.pg336
pmc: PMC10862618
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-342

Informations de copyright

© 2023 Okeke C et al.

Auteurs

Chizoba Okeke (C)

Nnamdi Azikiwe University.

Robert Okonkwo (R)

Nnamdi Azikiwe University Teaching Hospital.

Nancy Ibeh (N)

Nnamdi Azikiwe University.

Oluchukwu Chukwuma (O)

Nnamdi Azikiwe University.

Chisom Okeke (C)

Nnamdi Azikiwe University Teaching Hospital.

Classifications MeSH